Adoptive Cellular Immunotherapy
Adoptive Cellular Immunotherapy market is segmented by region (country), players, by Type and by ... Read More
1 Study Coverage 1.1 Chimeric Antigen Receptor Cell Therapy Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Introduction 1.2 Global Chimeric Antigen Receptor Cell Therapy Outlook 2017 VS 2022 VS 2028 1.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size for the Year 2017-2028 1.2.2 Global Chimeric Antigen Receptor Cell Therapy Market Size for the Year 2017-2028 1.3 Chimeric Antigen Receptor Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Chimeric Antigen Receptor Cell Therapy in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Chimeric Antigen Receptor Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Chimeric Antigen Receptor Cell Therapy Market Dynamics 1.4.1 Chimeric Antigen Receptor Cell Therapy Industry Trends 1.4.2 Chimeric Antigen Receptor Cell Therapy Market Drivers 1.4.3 Chimeric Antigen Receptor Cell Therapy Market Challenges 1.4.4 Chimeric Antigen Receptor Cell Therapy Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Chimeric Antigen Receptor Cell Therapy by Type 2.1 Chimeric Antigen Receptor Cell Therapy Market Segment by Type 2.1.1 Monotherapy 2.1.2 Combination Therapy 2.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017, 2022 & 2028) 2.3 Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2028) 2.4 United States Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017, 2022 & 2028) 2.5 United States Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2028) 3 Chimeric Antigen Receptor Cell Therapy by Application 3.1 Chimeric Antigen Receptor Cell Therapy Market Segment by Application 3.1.1 Acute Leukemia 3.1.2 Non-hodgkin's Lymphoma 3.1.3 Multiple Myeloma 3.1.4 Transplant Rejection 3.1.5 Other 3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017, 2022 & 2028) 3.3 Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2028) 3.4 United States Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017, 2022 & 2028) 3.5 United States Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2028) 4 Global Chimeric Antigen Receptor Cell Therapy Competitor Landscape by Company 4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Company 4.1.1 Top Global Chimeric Antigen Receptor Cell Therapy Companies Ranked by Revenue (2021) 4.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue by Player (2017-2022) 4.2 Global Chimeric Antigen Receptor Cell Therapy Concentration Ratio (CR) 4.2.1 Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Chimeric Antigen Receptor Cell Therapy in 2021 4.2.3 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Chimeric Antigen Receptor Cell Therapy Headquarters, Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Type 4.3.1 Global Chimeric Antigen Receptor Cell Therapy Headquarters and Area Served 4.3.2 Global Chimeric Antigen Receptor Cell Therapy Companies Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Chimeric Antigen Receptor Cell Therapy Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Chimeric Antigen Receptor Cell Therapy Market Size by Company 4.5.1 Top Chimeric Antigen Receptor Cell Therapy Players in United States, Ranked by Revenue (2021) 4.5.2 United States Chimeric Antigen Receptor Cell Therapy Revenue by Players (2020, 2021 & 2022) 5 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region 5.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2028) 5.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region: 2017-2022 5.2.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth 2017-2028 6.1.2 North America Chimeric Antigen Receptor Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth 2017-2028 6.3.2 Europe Chimeric Antigen Receptor Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth 2017-2028 6.4.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Amgen Inc 7.1.1 Amgen Inc Company Details 7.1.2 Amgen Inc Business Overview 7.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.1.5 Amgen Inc Recent Development 7.2 Autolus Therapeutics Plc 7.2.1 Autolus Therapeutics Plc Company Details 7.2.2 Autolus Therapeutics Plc Business Overview 7.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction 7.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.2.5 Autolus Therapeutics Plc Recent Development 7.3 Beijing Immunochina Medical Science & Technology Co Ltd 7.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details 7.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview 7.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development 7.4 Bellicum Pharmaceuticals Inc 7.4.1 Bellicum Pharmaceuticals Inc Company Details 7.4.2 Bellicum Pharmaceuticals Inc Business Overview 7.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.4.5 Bellicum Pharmaceuticals Inc Recent Development 7.5 Bristol-Myers Squibb Co 7.5.1 Bristol-Myers Squibb Co Company Details 7.5.2 Bristol-Myers Squibb Co Business Overview 7.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction 7.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.5.5 Bristol-Myers Squibb Co Recent Development 7.6 bluebird bio Inc 7.6.1 bluebird bio Inc Company Details 7.6.2 bluebird bio Inc Business Overview 7.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.6.5 bluebird bio Inc Recent Development 7.7 CARsgen Therapeutics Ltd 7.7.1 CARsgen Therapeutics Ltd Company Details 7.7.2 CARsgen Therapeutics Ltd Business Overview 7.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.7.5 CARsgen Therapeutics Ltd Recent Development 7.8 Celgene Corp 7.8.1 Celgene Corp Company Details 7.8.2 Celgene Corp Business Overview 7.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction 7.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.8.5 Celgene Corp Recent Development 7.9 Cell Medica Ltd 7.9.1 Cell Medica Ltd Company Details 7.9.2 Cell Medica Ltd Business Overview 7.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.9.5 Cell Medica Ltd Recent Development 7.10 Cellular Biomedicine Group Inc 7.10.1 Cellular Biomedicine Group Inc Company Details 7.10.2 Cellular Biomedicine Group Inc Business Overview 7.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.10.5 Cellular Biomedicine Group Inc Recent Development 7.11 Celularity Inc 7.11.1 Celularity Inc Company Details 7.11.2 Celularity Inc Business Overview 7.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.11.5 Celularity Inc Recent Development 7.12 Celyad SA 7.12.1 Celyad SA Company Details 7.12.2 Celyad SA Business Overview 7.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction 7.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.12.5 Celyad SA Recent Development 7.13 Daiichi Sankyo Co Ltd 7.13.1 Daiichi Sankyo Co Ltd Company Details 7.13.2 Daiichi Sankyo Co Ltd Business Overview 7.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.13.5 Daiichi Sankyo Co Ltd Recent Development 7.14 Fosun Pharmaceutical AG 7.14.1 Fosun Pharmaceutical AG Company Details 7.14.2 Fosun Pharmaceutical AG Business Overview 7.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction 7.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.14.5 Fosun Pharmaceutical AG Recent Development 7.15 Gilead Sciences Inc 7.15.1 Gilead Sciences Inc Company Details 7.15.2 Gilead Sciences Inc Business Overview 7.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.15.5 Gilead Sciences Inc Recent Development 7.16 Guangzhou Anjie Biomedical Technology Co Ltd 7.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details 7.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview 7.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development 7.17 Hangzhou Converd Co Ltd 7.17.1 Hangzhou Converd Co Ltd Company Details 7.17.2 Hangzhou Converd Co Ltd Business Overview 7.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.17.5 Hangzhou Converd Co Ltd Recent Development 7.18 Hebei Senlang Biotechnology Inc Ltd 7.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details 7.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview 7.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development 7.19 HRAIN Biotechnology Co Ltd 7.19.1 HRAIN Biotechnology Co Ltd Company Details 7.19.2 HRAIN Biotechnology Co Ltd Business Overview 7.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.19.5 HRAIN Biotechnology Co Ltd Recent Development 7.20 Juno Therapeutics Inc 7.20.1 Juno Therapeutics Inc Company Details 7.20.2 Juno Therapeutics Inc Business Overview 7.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.20.5 Juno Therapeutics Inc Recent Development 7.21 Kite Pharma Inc 7.21.1 Kite Pharma Inc Company Details 7.21.2 Kite Pharma Inc Business Overview 7.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.21.5 Kite Pharma Inc Recent Development 7.22 Nanjing Legend Biotech Co Ltd 7.22.1 Nanjing Legend Biotech Co Ltd Company Details 7.22.2 Nanjing Legend Biotech Co Ltd Business Overview 7.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.22.5 Nanjing Legend Biotech Co Ltd Recent Development 7.23 NantKwest Inc 7.23.1 NantKwest Inc Company Details 7.23.2 NantKwest Inc Business Overview 7.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.23.5 NantKwest Inc Recent Development 7.24 Nkarta Inc 7.24.1 Nkarta Inc Company Details 7.24.2 Nkarta Inc Business Overview 7.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.24.5 Nkarta Inc Recent Development 7.25 Novartis AG 7.25.1 Novartis AG Company Details 7.25.2 Novartis AG Business Overview 7.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction 7.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.25.5 Novartis AG Recent Development 7.26 Ono Pharmaceutical Co Ltd 7.26.1 Ono Pharmaceutical Co Ltd Company Details 7.26.2 Ono Pharmaceutical Co Ltd Business Overview 7.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.26.5 Ono Pharmaceutical Co Ltd Recent Development 7.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd 7.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details 7.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview 7.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 7.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development 7.28 Sorrento Therapeutics Inc 7.28.1 Sorrento Therapeutics Inc Company Details 7.28.2 Sorrento Therapeutics Inc Business Overview 7.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.28.5 Sorrento Therapeutics Inc Recent Development 7.29 Takara Bio Inc 7.29.1 Takara Bio Inc Company Details 7.29.2 Takara Bio Inc Business Overview 7.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction 7.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) 7.29.5 Takara Bio Inc Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Chimeric Antigen Receptor Cell Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Chimeric Antigen Receptor Cell Therapy Market Trends Table 3. Chimeric Antigen Receptor Cell Therapy Market Drivers Table 4. Chimeric Antigen Receptor Cell Therapy Market Challenges Table 5. Chimeric Antigen Receptor Cell Therapy Market Restraints Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Chimeric Antigen Receptor Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Chimeric Antigen Receptor Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Chimeric Antigen Receptor Cell Therapy Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Chimeric Antigen Receptor Cell Therapy Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Player, 2017-2022 Table 13. Global Chimeric Antigen Receptor Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Chimeric Antigen Receptor Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2021) Table 15. Top Players of Chimeric Antigen Receptor Cell Therapy in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Chimeric Antigen Receptor Cell Therapy Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Chimeric Antigen Receptor Cell Therapy Players in United States Market, Ranking by Revenue (2021) Table 20. United States Chimeric Antigen Receptor Cell Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Chimeric Antigen Receptor Cell Therapy Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Chimeric Antigen Receptor Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Chimeric Antigen Receptor Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Chimeric Antigen Receptor Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Amgen Inc Company Details Table 31. Amgen Inc Business Overview Table 32. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Table 33. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 34. Amgen Inc Recent Development Table 35. Autolus Therapeutics Plc Company Details Table 36. Autolus Therapeutics Plc Business Overview Table 37. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Table 38. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 39. Autolus Therapeutics Plc Recent Development Table 40. Beijing Immunochina Medical Science & Technology Co Ltd Company Details Table 41. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview Table 42. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 43. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 44. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development Table 45. Bellicum Pharmaceuticals Inc Company Details Table 46. Bellicum Pharmaceuticals Inc Business Overview Table 47. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Table 48. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 49. Bellicum Pharmaceuticals Inc Recent Development Table 50. Bristol-Myers Squibb Co Company Details Table 51. Bristol-Myers Squibb Co Business Overview Table 52. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Table 53. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 54. Bristol-Myers Squibb Co Recent Development Table 55. bluebird bio Inc Company Details Table 56. bluebird bio Inc Business Overview Table 57. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Table 58. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 59. bluebird bio Inc Recent Development Table 60. CARsgen Therapeutics Ltd Company Details Table 61. CARsgen Therapeutics Ltd Business Overview Table 62. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Table 63. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 64. CARsgen Therapeutics Ltd Recent Development Table 65. Celgene Corp Company Details Table 66. Celgene Corp Business Overview Table 67. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Table 68. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 69. Celgene Corp Recent Development Table 70. Cell Medica Ltd Company Details Table 71. Cell Medica Ltd Business Overview Table 72. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Table 73. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 74. Cell Medica Ltd Recent Development Table 75. Cellular Biomedicine Group Inc Company Details Table 76. Cellular Biomedicine Group Inc Business Overview Table 77. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Table 78. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 79. Cellular Biomedicine Group Inc Recent Development Table 80. Celularity Inc Company Details Table 81. Celularity Inc Business Overview Table 82. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Table 83. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 84. Celularity Inc Recent Development Table 85. Celyad SA Company Details Table 86. Celyad SA Business Overview Table 87. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Table 88. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 89. Celyad SA Recent Development Table 90. Daiichi Sankyo Co Ltd Company Details Table 91. Daiichi Sankyo Co Ltd Business Overview Table 92. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 93. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 94. Daiichi Sankyo Co Ltd Recent Development Table 95. Fosun Pharmaceutical AG Company Details Table 96. Fosun Pharmaceutical AG Business Overview Table 97. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Table 98. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 99. Fosun Pharmaceutical AG Recent Development Table 100. Gilead Sciences Inc Company Details Table 101. Gilead Sciences Inc Business Overview Table 102. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Table 103. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 104. Gilead Sciences Inc Recent Development Table 105. Guangzhou Anjie Biomedical Technology Co Ltd Company Details Table 106. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview Table 107. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 108. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 109. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development Table 110. Hangzhou Converd Co Ltd Company Details Table 111. Hangzhou Converd Co Ltd Business Overview Table 112. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 113. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 114. Hangzhou Converd Co Ltd Recent Development Table 115. Hebei Senlang Biotechnology Inc Ltd Company Details Table 116. Hebei Senlang Biotechnology Inc Ltd Business Overview Table 117. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Table 118. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 119. Hebei Senlang Biotechnology Inc Ltd Recent Development Table 120. HRAIN Biotechnology Co Ltd Company Details Table 121. HRAIN Biotechnology Co Ltd Business Overview Table 122. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 123. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 124. HRAIN Biotechnology Co Ltd Recent Development Table 125. Juno Therapeutics Inc Company Details Table 126. Juno Therapeutics Inc Business Overview Table 127. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Table 128. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 129. Juno Therapeutics Inc Recent Development Table 130. Kite Pharma Inc Company Details Table 131. Kite Pharma Inc Business Overview Table 132. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Table 133. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 134. Kite Pharma Inc Recent Development Table 135. Nanjing Legend Biotech Co Ltd Company Details Table 136. Nanjing Legend Biotech Co Ltd Business Overview Table 137. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 138. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 139. Nanjing Legend Biotech Co Ltd Recent Development Table 140. NantKwest Inc Company Details Table 141. NantKwest Inc Business Overview Table 142. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Table 143. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 144. NantKwest Inc Recent Development Table 145. Nkarta Inc Company Details Table 146. Nkarta Inc Business Overview Table 147. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Table 148. Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 149. Nkarta Inc Recent Development Table 150. Novartis AG Company Details Table 151. Novartis AG Business Overview Table 152. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Table 153. Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 154. Novartis AG Recent Development Table 155. Ono Pharmaceutical Co Ltd Company Details Table 156. Ono Pharmaceutical Co Ltd Business Overview Table 157. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 158. Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 159. Ono Pharmaceutical Co Ltd Recent Development Table 160. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details Table 161. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview Table 162. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 163. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 164. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development Table 165. Sorrento Therapeutics Inc Company Details Table 166. Sorrento Therapeutics Inc Business Overview Table 167. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Table 168. Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 169. Sorrento Therapeutics Inc Recent Development Table 170. Takara Bio Inc Company Details Table 171. Takara Bio Inc Business Overview Table 172. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Table 173. Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million) Table 174. Takara Bio Inc Recent Development Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. Chimeric Antigen Receptor Cell Therapy Product Picture Figure 2. Global Chimeric Antigen Receptor Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Chimeric Antigen Receptor Cell Therapy Market Size 2017-2028 (US$ Million) Figure 4. United States Chimeric Antigen Receptor Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Chimeric Antigen Receptor Cell Therapy Market Size 2017-2028 (US$ Million) Figure 6. United States Chimeric Antigen Receptor Cell Therapy Market Share in Global 2017-2028 Figure 7. Chimeric Antigen Receptor Cell Therapy Report Years Considered Figure 8. Product Picture of Monotherapy Figure 9. Product Picture of Combination Therapy Figure 10. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type in 2022 & 2028 Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028) Figure 13. United States Chimeric Antigen Receptor Cell Therapy Market Share by Type in 2022 & 2028 Figure 14. United States Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028) Figure 16. Product Picture of Acute Leukemia Figure 17. Product Picture of Non-hodgkin's Lymphoma Figure 18. Product Picture of Multiple Myeloma Figure 19. Product Picture of Transplant Rejection Figure 20. Product Picture of Other Figure 21. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application in 2022 & 2028 Figure 22. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2028) & (US$ Million) Figure 23. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028) Figure 24. United States Chimeric Antigen Receptor Cell Therapy Market Share by Application in 2022 & 2028 Figure 25. United States Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2028) & (US$ Million) Figure 26. United States Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028) Figure 27. North America Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 28. U.S. Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Canada Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 31. Germany Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. France Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. U.K. Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Italy Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Russia Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 37. China Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Japan Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. South Korea Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. India Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Australia Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Taiwan Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Indonesia Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Thailand Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Malaysia Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Philippines Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 48. Mexico Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Brazil Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Argentina Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 52. Turkey Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. U.A.E Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Amgen Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 56. Autolus Therapeutics Plc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 57. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 58. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 59. Bristol-Myers Squibb Co Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 60. bluebird bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 61. CARsgen Therapeutics Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 62. Celgene Corp Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 63. Cell Medica Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 64. Cellular Biomedicine Group Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 65. Celularity Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 66. Celyad SA Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 67. Daiichi Sankyo Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 68. Fosun Pharmaceutical AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 69. Gilead Sciences Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 70. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 71. Hangzhou Converd Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 72. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 73. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 74. Juno Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 75. Kite Pharma Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 76. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 77. NantKwest Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 78. Nkarta Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 79. Novartis AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 80. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 81. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 82. Sorrento Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 83. Takara Bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) Figure 84. Bottom-up and Top-down Approaches for This Report Figure 85. Data Triangulation Figure 86. Key Executives Interviewed
Amgen Inc Autolus Therapeutics Plc Beijing Immunochina Medical Science & Technology Co Ltd Bellicum Pharmaceuticals Inc Bristol-Myers Squibb Co bluebird bio Inc CARsgen Therapeutics Ltd Celgene Corp Cell Medica Ltd Cellular Biomedicine Group Inc Celularity Inc Celyad SA Daiichi Sankyo Co Ltd Fosun Pharmaceutical AG Gilead Sciences Inc Guangzhou Anjie Biomedical Technology Co Ltd Hangzhou Converd Co Ltd Hebei Senlang Biotechnology Inc Ltd HRAIN Biotechnology Co Ltd Juno Therapeutics Inc Kite Pharma Inc Nanjing Legend Biotech Co Ltd NantKwest Inc Nkarta Inc Novartis AG Ono Pharmaceutical Co Ltd Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Sorrento Therapeutics Inc Takara Bio Inc
Adoptive Cellular Immunotherapy market is segmented by region (country), players, by Type and by ... Read More
XYZ Color Sensors market is segmented by region (country), players, by Type and by Application. P ... Read More
CoolSculpting/Zeltiq market is segmented by region (country), players, by Type and by Application ... Read More
2,2'-Diallyl-4,4'-Sulfonyldiphenol market is segmented by region (country), players, by Type and ... Read More